This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Fat embolism syndrome

Authoring team

Fat Embolism Syndrome (FES)

  • potentially fatal complication of long bone fractures

  • classically described as the triad of hypoxia, petechiae, and neurological impairment

  • characterized by bone marrow fat entering the systemic circulation and the individual's inflammatory response to it
    • response can result in dysfunction of several organs, most importantly the lungs, brain, and skin

  • although fat embolization occurs in the majority of patients with long bone fractures or during orthopedic procedures, clinical signs and symptoms occur in only 1-10% of these patients
    • most of the reported cases occurred in patients with multiple traumatic injuries that resulted in the systemic inflammatory response syndrome, which causes multi-organ damage via a reaction to free fatty acids
    • non-traumatic causes of FES
      • non-traumatic conditions are very uncommon causes of FES; they are acute pancreatitis, fatty liver, corticosteroid therapy, lymphography, fat emulsion infusion and haemoglobinopathies

Reference:

  • Gurd AR, Wilson RI. The fat embolism syndrome. J Bone Joint Surg (Br) 1974;7:408-416.
  • Robinson CM. Current concepts of respiratory insufficiency syndromes after fracture. J Bone Joint Surg (Br) 2001;7:781-791.
  • Shaikh N. Emergency management of fat embolism syndrome. J Emerg Trauma Shock. 2009 Jan;2(1):29-33.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.